1. Resolution RDC No. 301/2019. Provides for the General Guidelines for Good Practices in the Manufacturing of Medicines; Brasília, DF: Brazilian Ministry of Health, Brazilian Health Regulatory Agency (ANVISA), 2019. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-301-de-21-de-agosto-de-2019-211914064. (access Apr 15, 2021).
2. Resolution RDC No. 318/2019. Establishes the Criteria for Carrying out Stability Studies on Active Pharmaceutical Ingredients and Drugs, Except Biologicals; Brasília, DF: Brazilian Ministry of Health, Brazilian Health Regulatory Agency (ANVISA), 2019. https://www.in.gov.br/web/dou/-/resolucao-rdc-n-318-de-6-de-novembro-de-2019-226513805. (access Apr 15, 2021).
3. PubChem CID 3111. Metamizole; Bethesda, MD: US National Institute of Health, National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/Metamizole. (accessed Sept 4, 2020).
4. European Pharmacopeia 7th ed.; Strasbourg, France: Council of Europe, European Pharmacopoeia Comission, European Directorate for the Quality of Medicines and Healthcare, 2010.
5. Brazilian Pharmacopoeia 6th ed.; Brasília, DF, Brazil: Brazilian Ministry of Health, Brazilian Health Regulatory Agency (ANVISA), 2019.